Feeling drained? These ‘battery drainers' are zapping all your energy: study
If you're tired reading this, you're not alone. One in three Americans are drained before the day even starts.
And what precious energy they do have is quickly zapped away, according to a survey of 2,000 people which pinpointed what drains Americans' energy the most.
Results showed that the pain of being interrupted, being forced to engage in awkward small talk and being on the receiving end of unsolicited advice are some of the biggest 'battery drainers,' according to new research.
The survey conducted by Talker Research on behalf of Zipfizz examined the energy levels of 2,000 Americans and asked them to name the things that zap their energy day to day and their social stamina.
7 One in three Americans are drained before the day even starts.
Getty Images/iStockphoto
Dull interactions, even duller weather and worries over finances were among the most common drains.
Additional social energy suckers were dealing with office gossip (6%), being subjected to overly personal conversations with coworkers (4%) and colleagues showing you something on their phone (3%).
No wonder then a further one in three blamed their jobs for leaving them drained.
And it's not just our jobs leaving us drained. The survey also found the biggest hits to our physical energy were lack of quality sleep (42%) and the never-ending cycle of housework (28%).
7 Some of the biggest 'battery drainers' are being interrupted and being forced to engage in awkward small talk.
SWNS
While 56% of participants said they believe staying hydrated plays a key role in their energy levels, the average reported water intake was just 5.3 cups per day, well below the recommended 15.5.
And that lack of hydration, sleep and social drainage all take their toll with many Americans reporting crashes during the day.The average American starts to fade by 11:54 a.m. — right before lunch.
So how do people power through the dreaded mid-day slump? A quick caffeine fix (25%), turning up the music (15%) or sneaking in a nap (14%) are the go-to energy boosts for getting through the day.
7 Additional social energy suckers were dealing with office gossip (6%) and being subjected to overly personal conversations with coworkers (4%).
Getty Images
Thirteen percent reported exercising or mindful movement, while 8% said they take a break to enjoy the outdoors if they feel their energy crash during the day.
'This survey really shows how quickly our energy can take a hit — even before lunchtime,' said Marcela Kanalos, spokesperson for Zipfizz. 'From housework to weather, it's the small, constant drains that add up. Knowing how to recover from that dip can make all the difference.'
And when the weekend finally hits? For 48%, it doesn't bring the relief they hoped for — they're still feeling wiped out.
More than a quarter (28%) believe that making small habit changes, like drinking more water, can have a significant impact on how energized they feel.
7 The survey also found the biggest hits to our physical energy were lack of quality sleep and the never-ending cycle of housework.
SWNS
7 The average participant reported water intake was just 5.3 cups per day, well below the recommended 15.5.
SWNS
When asked what they'd do if they could reclaim just one hour of daily energy, their answers revealed what many are missing most: time to unwind.
The top choice was simply relaxing (15%), followed by being physically active or exercising (14%) —and ironically — getting more sleep (13%).
Others said they would spend more quality time with friends or family (10%) and catch up on chores (9%).
7 48% of participants said the weekend doesn't bring the relief they hoped for — and that they're still feeling wiped out.
Prostock-studio – stock.adobe.com
'When people are running on empty before noon and the weekend doesn't offer the recovery they hoped for, it's a sign that quick fixes aren't enough,' added Kanalos. 'Real energy comes from small, consistent choices — like better sleep, hydration and meaningful downtime — that add up over time. We don't just need to push through the day; we need to learn how to recharge in ways that actually last.'
TOP 10 BIGGEST SOCIAL BATTERY ZAPPERS
Being interrupted or talked over (15%) Awkward small talk (11%) Customer service interactions (9%) Talking to strangers (9%) Unsolicited advice (8%) Office gossip (6%) Group video calls (4%) Overly personal conversations with coworkers (4%) Coworkers showing you something on their phone (3%) Networking events (3%)
BIGGEST ENERGY SUCKERS
7 More than a quarter believe that making small habit changes, like drinking more water, can have a significant impact on how energized they feel.
SWNS
Lack of quality sleep (42%) Housework/chores (28%) Finance worries (26%) Bad weather (20%) Dull social interactions (19%)
Survey methodology:
Talker Research surveyed 2,000 Americans; the survey was commissioned by Zipfizz and administered and conducted online by Talker Research between May 1 – May 5, 2025.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
11 minutes ago
- The Hill
FDA to offer faster drug reviews to companies promoting ‘national priorities'
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting 'the health interests of Americans,' under a new initiative announced Tuesday. Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months. Since arriving at the FDA in April, Makary has repeatedly told FDA staff they need to 'challenge assumptions' and rethink procedures. In a medical journal commentary published last week, Makary suggested the agency could conduct 'rapid or instant reviews,' pointing to the truncated process used to authorize the first COVID-19 vaccines under Operation Warp Speed. For the new program, the FDA will issue a limited number of 'national priority vouchers' to companies 'aligned with U.S. national priorities,' the agency said in a statement. The special designation will give the selected companies access to extra FDA communications, streamlined staff reviews and the ability to submit much of their product information in advance. Speeding up drug approvals has long been a priority of the pharmaceutical industry, which has successfully lobbied Congress to create a variety of special programs and pathways for faster reviews. Many aspects of the plan announced Tuesday overlap with older programs. But the broad criteria for receiving a voucher will give FDA officials unprecedented discretion in deciding which companies can benefit from the fastest reviews. 'The ultimate goal is to bring more cures and meaningful treatments to the American public,' Makary said in a statement. Makary previously said the FDA should be willing to ease its scientific requirements for certain drugs, for instance, by not always requiring randomized studies in which patients are tracked over time to track safety and effectiveness. Such trials are generally considered the gold standard of medical research, though the FDA has increasingly been willing to accept smaller, less-definitive studies for rare or life-threatening diseases. In several recent cases, the FDA has faced criticism for approving drugs based on preliminary data that didn't ultimately show benefits for patients. The push to rapidly accelerated drug approvals is the opposite approach that Makary and his boss, Health Secretary Robert F. Kennedy Jr., have taken on vaccines. Promising a 'return to gold-standard science,' Kennedy previously announced that all new vaccines would have to be compared to placebo, or a dummy shot, to win approval. Kennedy and Makary also have announced a stricter policy on seasonal updates to COVID-19 shots, saying they will have to undergo new testing before they can be approved for use in healthy children and most adults. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hamilton Spectator
42 minutes ago
- Hamilton Spectator
FDA to offer faster drug reviews to companies promoting ‘national priorities'
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting 'the health interests of Americans,' under a new initiative announced Tuesday. Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases . Regular drug reviews take about 10 months. Since arriving at the FDA in April, Makary has repeatedly told FDA staff they need to 'challenge assumptions' and rethink procedures. In a medical journal commentary published last week, Makary suggested the agency could conduct 'rapid or instant reviews,' pointing to the truncated process used to authorize the first COVID-19 vaccines under Operation Warp Speed. For the new program, the FDA will issue a limited number of 'national priority vouchers' to companies 'aligned with U.S. national priorities,' the agency said in a statement. The special designation will give the selected companies access to extra FDA communications, streamlined staff reviews and the ability to submit much of their product information in advance. Speeding up drug approvals has long been a priority of the pharmaceutical industry, which has successfully lobbied Congress to create a variety of special programs and pathways for faster reviews. Many aspects of the plan announced Tuesday overlap with older programs. But the broad criteria for receiving a voucher will give FDA officials unprecedented discretion in deciding which companies can benefit from the fastest reviews. 'The ultimate goal is to bring more cures and meaningful treatments to the American public,' Makary said in a statement. Makary previously said the FDA should be willing to ease its scientific requirements for certain drugs, for instance, by not always requiring randomized studies in which patients are tracked over time to track safety and effectiveness. Such trials are generally considered the gold standard of medical research, though the FDA has increasingly been willing to accept smaller, less-definitive studies for rare or life-threatening diseases . In several recent cases , the FDA has faced criticism for approving drugs based on preliminary data that didn't ultimately show benefits for patients. The push to rapidly accelerated drug approvals is the opposite approach that Makary and his boss, Health Secretary Robert F. Kennedy Jr. , have taken on vaccines. Promising a 'return to gold-standard science,' Kennedy previously announced that all new vaccines would have to be compared to placebo, or a dummy shot, to win approval. Kennedy and Makary also have announced a stricter policy on seasonal updates to COVID-19 shots, saying they will have to undergo new testing before they can be approved for use in healthy children and most adults. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Politico
an hour ago
- Politico
GOP megabill faces grim polling for Republicans
As the Senate continues to work through the House-passed megabill, the public's opinion of the legislation is starting to shape — and so far it's not looking good for Republicans. A series of polls released in recent days have revealed the bill, which would be President Donald Trump's signature piece of legislation in his second term's first year, is broadly unpopular except with self-proclaimed MAGA Republicans. The 'One Big Beautiful Bill Act', which narrowly passed the House late last month, includes tax changes and Medicaid cuts, two key issues that are still being debated by the Senate as it rushes to meet Trump's July 4 deadline. Here are three takeaways from the recent surveys: Three separate polls released in the last week showed that more Americans who are aware of the legislation do not support it, though the split remains largely along party lines. A Washington Post-Ipsos poll released Tuesday found that 42 percent of Americans are not in favor of the bill, while 23 percent support it and 34 percent say they have no opinion. A KFF Health Tracking poll also found more adults dislike the bill than support it, with 64 percent of adults having an unfavorable view of the legislation and 35 percent having a favorable view. Meanwhile, a Quinnipiac University poll released last week found that 53 percent of voters oppose the bill, with 27 percent supporting and 20 percent not offering an opinion. Separated along party lines, a majority of Republicans who have an opinion support the legislation, but not by the margin in which Democrats oppose it. Across the three polls, 49 percent to 61 percent of Republicans support the bill. Among Democrats, however, 70 percent to 90 percent are against it. The KFF Health Tracking poll asked Republicans and Republican-leaning independents if they are a 'supporter of the MAGA movement,' which revealed a further split in the polling. Among self-professed MAGA Republicans, support for the bill went up to 72 percent, while Republicans who did not identify as part of the MAGA movement held an unfavorable view of the bill at a 2-to-1 margin, 66 percent to 33 percent. Since the House passed the megabill, Democrats have worked to define the bill by its reductions to Medicaid spending. The fresh round of polling shows their messaging may be having some success. In the Quinnipiac poll, just 10 percent of voters said federal funding to Medicaid should decrease, and 47 percent of voters surveyed favored increased funding for the program. When asked about the bill's Medicaid cuts, 67 percent of adults surveyed in the KFF poll said the decrease in funding left them with an unfavorable view of the bill. But work requirements — one of the changes to Medicaid championed by Republicans — has broad support. In The Washington Post-Ipsos poll, 52 percent of adults said they support 'requiring low-income childless adults to prove they are working or disabled to get health insurance through Medicaid,' compared with 33 percent who oppose the requirement (15 percent had no opinion). KFF's poll showed even greater support for the work requirements, at 68 percent, including half of Democrats and nine in 10 Republicans. However, when respondents were informed of some of the barriers that work requirements create — like filing paperwork to prove eligibility — support dropped in both polls. Across all of the polls, most Americans still haven't heard of Republicans' premier piece of legislation, which gives both parties the opportunity to shift public opinion with their messaging. In The Washington Post-Ipsos poll, 66 percent of adults said they had heard little or nothing at all about the bill, compared with 34 percent who had heard a great deal or a good amount. In KFF's poll, 50 percent of adults said they had heard little or nothing at all about the legislation. In the Quinnipiac poll, a majority of voters were aware of the bill, with 36 percent saying they have heard or read 'a lot' and 32 percent saying they have heard or read 'some.' Fourteen percent said they had heard or read 'not too much' and 18 percent said 'not much at all.' The Quinnipiac poll surveyed 1,265 self-identified registered voters from June 5-9, and had a margin of error of plus or minus 2.8 percent. The Washington Post-Ipsos poll was conducted from June 6-10 and surveyed 1,167 U.S. adults with a margin of error of plus or minus 3 percent. The KFF Health Tracking poll was conducted June 4-8 and surveyed 1,321 U.S. adults, with a margin of error of plus or minus 3 percent.
